 | • レポートコード：MRC2312MG08466 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、158ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の非侵襲的着床前遺伝子検査市場規模と予測を収録しています。・世界の非侵襲的着床前遺伝子検査市場：売上、2018年-2023年、2024年-2029年 ・世界の非侵襲的着床前遺伝子検査市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の非侵襲的着床前遺伝子検査市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「着床前遺伝子スクリーニング」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 非侵襲的着床前遺伝子検査のグローバル主要企業は、Illumina、 Thermo Fisher Scientific、 Agilent、 Revvity、 The Cooper Companies、 Abbott、 TAKARA、 QIAGEN、 Vitrolife、 Oxford Nanopore Technologies、 Yikon Genomics、 Shiva Scientific、 Medicover Genetics、 MedGenome、 Fulgent、 INVICTA GENETICS、 Genea Fertility、 Bioarray、 GeneMind Biosciences、 Unimed Biotechなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、非侵襲的着床前遺伝子検査のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の非侵襲的着床前遺伝子検査市場：タイプ別、2018年-2023年、2024年-2029年 世界の非侵襲的着床前遺伝子検査市場：タイプ別市場シェア、2022年 ・着床前遺伝子スクリーニング、着床前遺伝子診断 世界の非侵襲的着床前遺伝子検査市場：用途別、2018年-2023年、2024年-2029年 世界の非侵襲的着床前遺伝子検査市場：用途別市場シェア、2022年 ・病院、検査機関、その他 世界の非侵襲的着床前遺伝子検査市場：地域・国別、2018年-2023年、2024年-2029年 世界の非侵襲的着床前遺伝子検査市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における非侵襲的着床前遺伝子検査のグローバル売上、2018年-2023年 ・主要企業における非侵襲的着床前遺伝子検査のグローバル売上シェア、2022年 ・主要企業における非侵襲的着床前遺伝子検査のグローバル販売量、2018年-2023年 ・主要企業における非侵襲的着床前遺伝子検査のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Illumina、 Thermo Fisher Scientific、 Agilent、 Revvity、 The Cooper Companies、 Abbott、 TAKARA、 QIAGEN、 Vitrolife、 Oxford Nanopore Technologies、 Yikon Genomics、 Shiva Scientific、 Medicover Genetics、 MedGenome、 Fulgent、 INVICTA GENETICS、 Genea Fertility、 Bioarray、 GeneMind Biosciences、 Unimed Biotech ************************************************************* ・調査・分析レポートの概要 非侵襲的着床前遺伝子検査市場の定義 市場セグメント 世界の非侵襲的着床前遺伝子検査市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の非侵襲的着床前遺伝子検査市場規模 世界の非侵襲的着床前遺伝子検査市場規模：2022年 VS 2029年 世界の非侵襲的着床前遺伝子検査市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの非侵襲的着床前遺伝子検査の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の非侵襲的着床前遺伝子検査製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：着床前遺伝子スクリーニング、着床前遺伝子診断 非侵襲的着床前遺伝子検査のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、検査機関、その他 非侵襲的着床前遺伝子検査の用途別グローバル売上・予測 ・地域別市場分析 地域別非侵襲的着床前遺伝子検査市場規模 2022年と2029年 地域別非侵襲的着床前遺伝子検査売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Illumina、 Thermo Fisher Scientific、 Agilent、 Revvity、 The Cooper Companies、 Abbott、 TAKARA、 QIAGEN、 Vitrolife、 Oxford Nanopore Technologies、 Yikon Genomics、 Shiva Scientific、 Medicover Genetics、 MedGenome、 Fulgent、 INVICTA GENETICS、 Genea Fertility、 Bioarray、 GeneMind Biosciences、 Unimed Biotech ... |
This research report provides a comprehensive analysis of the Non-invasive Preimplantation Genetic Testing market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Non-invasive Preimplantation Genetic Testing market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Non-invasive Preimplantation Genetic Testing, challenges faced by the industry, and potential opportunities for market players.
The global Non-invasive Preimplantation Genetic Testing market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Non-invasive Preimplantation Genetic Testing market presents opportunities for various stakeholders, including Hospitals, Diagnostic Laboratories. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Non-invasive Preimplantation Genetic Testing market. Additionally, the growing consumer demand present avenues for market expansion.
The global Non-invasive Preimplantation Genetic Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Non-invasive Preimplantation Genetic Testing market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Non-invasive Preimplantation Genetic Testing market.
Market Overview: The report provides a comprehensive overview of the Non-invasive Preimplantation Genetic Testing market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Non-invasive Preimplantation Genetic Testing market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Non-invasive Preimplantation Genetic Testing market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Non-invasive Preimplantation Genetic Testing market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Non-invasive Preimplantation Genetic Testing market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Non-invasive Preimplantation Genetic Testing market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Non-invasive Preimplantation Genetic Testing market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Non-invasive Preimplantation Genetic Testing, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Non-invasive Preimplantation Genetic Testing market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Non-invasive Preimplantation Genetic Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
Market segment by Application
Hospitals
Diagnostic Laboratories
Other
Global Non-invasive Preimplantation Genetic Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Illumina
Thermo Fisher Scientific
Agilent
Revvity
The Cooper Companies
Abbott
TAKARA
QIAGEN
Vitrolife
Oxford Nanopore Technologies
Yikon Genomics
Shiva Scientific
Medicover Genetics
MedGenome
Fulgent
INVICTA GENETICS
Genea Fertility
Bioarray
GeneMind Biosciences
Unimed Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-invasive Preimplantation Genetic Testing, market overview.
Chapter 2: Global Non-invasive Preimplantation Genetic Testing market size in revenue and volume.
Chapter 3: Detailed analysis of Non-invasive Preimplantation Genetic Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-invasive Preimplantation Genetic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Non-invasive Preimplantation Genetic Testing capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Non-invasive Preimplantation Genetic Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-invasive Preimplantation Genetic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-invasive Preimplantation Genetic Testing Overall Market Size
2.1 Global Non-invasive Preimplantation Genetic Testing Market Size: 2022 VS 2029
2.2 Global Non-invasive Preimplantation Genetic Testing Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Non-invasive Preimplantation Genetic Testing Sales: 2018-2029
3 Company Landscape
3.1 Top Non-invasive Preimplantation Genetic Testing Players in Global Market
3.2 Top Global Non-invasive Preimplantation Genetic Testing Companies Ranked by Revenue
3.3 Global Non-invasive Preimplantation Genetic Testing Revenue by Companies
3.4 Global Non-invasive Preimplantation Genetic Testing Sales by Companies
3.5 Global Non-invasive Preimplantation Genetic Testing Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Non-invasive Preimplantation Genetic Testing Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Non-invasive Preimplantation Genetic Testing Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-invasive Preimplantation Genetic Testing Players in Global Market
3.8.1 List of Global Tier 1 Non-invasive Preimplantation Genetic Testing Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-invasive Preimplantation Genetic Testing Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Non-invasive Preimplantation Genetic Testing Market Size Markets, 2022 & 2029
4.1.2 Preimplantation Genetic Screening
4.1.3 Preimplantation Genetic Diagnosis
4.2 By Type – Global Non-invasive Preimplantation Genetic Testing Revenue & Forecasts
4.2.1 By Type – Global Non-invasive Preimplantation Genetic Testing Revenue, 2018-2023
4.2.2 By Type – Global Non-invasive Preimplantation Genetic Testing Revenue, 2024-2029
4.2.3 By Type – Global Non-invasive Preimplantation Genetic Testing Revenue Market Share, 2018-2029
4.3 By Type – Global Non-invasive Preimplantation Genetic Testing Sales & Forecasts
4.3.1 By Type – Global Non-invasive Preimplantation Genetic Testing Sales, 2018-2023
4.3.2 By Type – Global Non-invasive Preimplantation Genetic Testing Sales, 2024-2029
4.3.3 By Type – Global Non-invasive Preimplantation Genetic Testing Sales Market Share, 2018-2029
4.4 By Type – Global Non-invasive Preimplantation Genetic Testing Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Non-invasive Preimplantation Genetic Testing Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Diagnostic Laboratories
5.1.4 Other
5.2 By Application – Global Non-invasive Preimplantation Genetic Testing Revenue & Forecasts
5.2.1 By Application – Global Non-invasive Preimplantation Genetic Testing Revenue, 2018-2023
5.2.2 By Application – Global Non-invasive Preimplantation Genetic Testing Revenue, 2024-2029
5.2.3 By Application – Global Non-invasive Preimplantation Genetic Testing Revenue Market Share, 2018-2029
5.3 By Application – Global Non-invasive Preimplantation Genetic Testing Sales & Forecasts
5.3.1 By Application – Global Non-invasive Preimplantation Genetic Testing Sales, 2018-2023
5.3.2 By Application – Global Non-invasive Preimplantation Genetic Testing Sales, 2024-2029
5.3.3 By Application – Global Non-invasive Preimplantation Genetic Testing Sales Market Share, 2018-2029
5.4 By Application – Global Non-invasive Preimplantation Genetic Testing Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Non-invasive Preimplantation Genetic Testing Market Size, 2022 & 2029
6.2 By Region – Global Non-invasive Preimplantation Genetic Testing Revenue & Forecasts
6.2.1 By Region – Global Non-invasive Preimplantation Genetic Testing Revenue, 2018-2023
6.2.2 By Region – Global Non-invasive Preimplantation Genetic Testing Revenue, 2024-2029
6.2.3 By Region – Global Non-invasive Preimplantation Genetic Testing Revenue Market Share, 2018-2029
6.3 By Region – Global Non-invasive Preimplantation Genetic Testing Sales & Forecasts
6.3.1 By Region – Global Non-invasive Preimplantation Genetic Testing Sales, 2018-2023
6.3.2 By Region – Global Non-invasive Preimplantation Genetic Testing Sales, 2024-2029
6.3.3 By Region – Global Non-invasive Preimplantation Genetic Testing Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Non-invasive Preimplantation Genetic Testing Revenue, 2018-2029
6.4.2 By Country – North America Non-invasive Preimplantation Genetic Testing Sales, 2018-2029
6.4.3 US Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.4.4 Canada Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.4.5 Mexico Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Non-invasive Preimplantation Genetic Testing Revenue, 2018-2029
6.5.2 By Country – Europe Non-invasive Preimplantation Genetic Testing Sales, 2018-2029
6.5.3 Germany Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.5.4 France Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.5.5 U.K. Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.5.6 Italy Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.5.7 Russia Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.5.8 Nordic Countries Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.5.9 Benelux Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Non-invasive Preimplantation Genetic Testing Revenue, 2018-2029
6.6.2 By Region – Asia Non-invasive Preimplantation Genetic Testing Sales, 2018-2029
6.6.3 China Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.6.4 Japan Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.6.5 South Korea Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.6.6 Southeast Asia Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.6.7 India Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Non-invasive Preimplantation Genetic Testing Revenue, 2018-2029
6.7.2 By Country – South America Non-invasive Preimplantation Genetic Testing Sales, 2018-2029
6.7.3 Brazil Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.7.4 Argentina Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales, 2018-2029
6.8.3 Turkey Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.8.4 Israel Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.8.5 Saudi Arabia Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.8.6 UAE Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Illumina
7.1.1 Illumina Company Summary
7.1.2 Illumina Business Overview
7.1.3 Illumina Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.1.4 Illumina Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.1.5 Illumina Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.2.4 Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 Agilent
7.3.1 Agilent Company Summary
7.3.2 Agilent Business Overview
7.3.3 Agilent Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.3.4 Agilent Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.3.5 Agilent Key News & Latest Developments
7.4 Revvity
7.4.1 Revvity Company Summary
7.4.2 Revvity Business Overview
7.4.3 Revvity Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.4.4 Revvity Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.4.5 Revvity Key News & Latest Developments
7.5 The Cooper Companies
7.5.1 The Cooper Companies Company Summary
7.5.2 The Cooper Companies Business Overview
7.5.3 The Cooper Companies Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.5.4 The Cooper Companies Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.5.5 The Cooper Companies Key News & Latest Developments
7.6 Abbott
7.6.1 Abbott Company Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.6.4 Abbott Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.6.5 Abbott Key News & Latest Developments
7.7 TAKARA
7.7.1 TAKARA Company Summary
7.7.2 TAKARA Business Overview
7.7.3 TAKARA Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.7.4 TAKARA Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.7.5 TAKARA Key News & Latest Developments
7.8 QIAGEN
7.8.1 QIAGEN Company Summary
7.8.2 QIAGEN Business Overview
7.8.3 QIAGEN Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.8.4 QIAGEN Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.8.5 QIAGEN Key News & Latest Developments
7.9 Vitrolife
7.9.1 Vitrolife Company Summary
7.9.2 Vitrolife Business Overview
7.9.3 Vitrolife Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.9.4 Vitrolife Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.9.5 Vitrolife Key News & Latest Developments
7.10 Oxford Nanopore Technologies
7.10.1 Oxford Nanopore Technologies Company Summary
7.10.2 Oxford Nanopore Technologies Business Overview
7.10.3 Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.10.4 Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.10.5 Oxford Nanopore Technologies Key News & Latest Developments
7.11 Yikon Genomics
7.11.1 Yikon Genomics Company Summary
7.11.2 Yikon Genomics Business Overview
7.11.3 Yikon Genomics Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.11.4 Yikon Genomics Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.11.5 Yikon Genomics Key News & Latest Developments
7.12 Shiva Scientific
7.12.1 Shiva Scientific Company Summary
7.12.2 Shiva Scientific Business Overview
7.12.3 Shiva Scientific Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.12.4 Shiva Scientific Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.12.5 Shiva Scientific Key News & Latest Developments
7.13 Medicover Genetics
7.13.1 Medicover Genetics Company Summary
7.13.2 Medicover Genetics Business Overview
7.13.3 Medicover Genetics Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.13.4 Medicover Genetics Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.13.5 Medicover Genetics Key News & Latest Developments
7.14 MedGenome
7.14.1 MedGenome Company Summary
7.14.2 MedGenome Business Overview
7.14.3 MedGenome Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.14.4 MedGenome Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.14.5 MedGenome Key News & Latest Developments
7.15 Fulgent
7.15.1 Fulgent Company Summary
7.15.2 Fulgent Business Overview
7.15.3 Fulgent Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.15.4 Fulgent Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.15.5 Fulgent Key News & Latest Developments
7.16 INVICTA GENETICS
7.16.1 INVICTA GENETICS Company Summary
7.16.2 INVICTA GENETICS Business Overview
7.16.3 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.16.4 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.16.5 INVICTA GENETICS Key News & Latest Developments
7.17 Genea Fertility
7.17.1 Genea Fertility Company Summary
7.17.2 Genea Fertility Business Overview
7.17.3 Genea Fertility Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.17.4 Genea Fertility Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.17.5 Genea Fertility Key News & Latest Developments
7.18 Bioarray
7.18.1 Bioarray Company Summary
7.18.2 Bioarray Business Overview
7.18.3 Bioarray Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.18.4 Bioarray Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.18.5 Bioarray Key News & Latest Developments
7.19 GeneMind Biosciences
7.19.1 GeneMind Biosciences Company Summary
7.19.2 GeneMind Biosciences Business Overview
7.19.3 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.19.4 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.19.5 GeneMind Biosciences Key News & Latest Developments
7.20 Unimed Biotech
7.20.1 Unimed Biotech Company Summary
7.20.2 Unimed Biotech Business Overview
7.20.3 Unimed Biotech Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.20.4 Unimed Biotech Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.20.5 Unimed Biotech Key News & Latest Developments
8 Global Non-invasive Preimplantation Genetic Testing Production Capacity, Analysis
8.1 Global Non-invasive Preimplantation Genetic Testing Production Capacity, 2018-2029
8.2 Non-invasive Preimplantation Genetic Testing Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-invasive Preimplantation Genetic Testing Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-invasive Preimplantation Genetic Testing Supply Chain Analysis
10.1 Non-invasive Preimplantation Genetic Testing Industry Value Chain
10.2 Non-invasive Preimplantation Genetic Testing Upstream Market
10.3 Non-invasive Preimplantation Genetic Testing Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-invasive Preimplantation Genetic Testing Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer